Advancing preclinical COVID-19 Coronavirus program leveraging patent rights recently acquired from Kansas State University Research Foundation (“KSURF”)Continuing collaboration with Merck […]
SAINT-MICHEL-DES-SAINTS, Quebec, March 30, 2020 (GLOBE NEWSWIRE) — Despite the social and economic disruptions brought about by the COVID-19 pandemic, […]
YONKERS, N.Y., March 30, 2020 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery and […]